Alx Oncology Holdings Inc (ALXO)

11:45 AM

Can ALX Oncology Holdings Inc. stock attract ESG capital inflowsJuly 2025 Snapshot & Risk Controlled Daily Trade Plans - newser.com

11:45 AM

09:40 AM

Is Alnylam Pharmaceuticals (ALNY) Outperforming Other Medical Stocks This Year? - Yahoo Finance

09:40 AM

05:19 AM

Will ALX Oncology Holdings Inc. benefit from macro trendsJuly 2025 Fed Impact & AI Based Buy and Sell Signals - newser.com

05:19 AM

04:29 AM

Analyzing ALX Oncology Holdings Inc. with risk reward ratio charts2025 Historical Comparison & Reliable Trade Execution Plans - newser.com

04:29 AM

04:06 AM

Relative strength of ALX Oncology Holdings Inc. in sector analysis2025 Price Momentum & Weekly High Return Forecasts - newser.com

04:06 AM

03:12 AM

Will ALX Oncology Holdings Inc. stock reach Wall Street targetsJuly 2025 Decliners & Free Daily Entry Point Trade Alerts - newser.com

03:12 AM

Oct 13, 2025

Key metrics from ALX Oncology Holdings Inc.’s quarterly dataJuly 2025 Reactions & Fast Exit/Entry Strategy Plans - newser.com

Oct 13, 2025

Oct 10, 2025

Real time breakdown of ALX Oncology Holdings Inc. stock performanceCEO Change & High Return Trade Opportunity Guides - newser.com

Oct 10, 2025

Oct 10, 2025

Is ALX Oncology Holdings Inc a good long term investmentMoving Average Crossovers & Free High Yield Market Plays - earlytimes.in

Oct 10, 2025

Oct 10, 2025

Chart based analysis of ALX Oncology Holdings Inc. trendsMarket Activity Recap & Entry Point Confirmation Alerts - newser.com

Oct 10, 2025

Oct 08, 2025

ALX Oncology (NASDAQ:ALXO) Given "Sell (D-)" Rating at Weiss Ratings - MarketBeat

Oct 08, 2025

Oct 06, 2025

How moving averages guide ALX Oncology Holdings Inc. trading2025 EndofYear Setup & Low Risk High Reward Ideas - newser.com

Oct 06, 2025

Oct 05, 2025

Is ALX Oncology Holdings Inc. still worth holding after the dipJuly 2025 News Drivers & Daily Profit Maximizing Tips - newser.com

Oct 05, 2025

Oct 04, 2025

ALX Oncology to Present Updated Data from Phase 2 ASPEN-06 - GlobeNewswire

Oct 04, 2025

Oct 03, 2025

ALX Oncology to present CD47 biomarker data for evorpacept at SITC - Investing.com Nigeria

Oct 03, 2025

Oct 03, 2025

ALX Oncology to present CD47 biomarker data for evorpacept at SITC By Investing.com - Investing.com South Africa

Oct 03, 2025

Oct 03, 2025

ALX Oncology Presents Phase 2 ASPEN-06: CD47 Biomarker in HER2+ Gastric Cancer | ALXO Stock News - Stock Titan

Oct 03, 2025

Oct 01, 2025

ALX Oncology Holdings Inc Stock Analysis and ForecastGrowth vs. Value Investing & Exceptional Return Investment - earlytimes.in

Oct 01, 2025

Sep 30, 2025

Revolution Medicines hires Mirati, ALX vet Sandler - biocentury.com

Sep 30, 2025

Sep 30, 2025

ALX Oncology Holdings (ALXO) Price Target Increased by 18.52% to 2.72 - Nasdaq

Sep 30, 2025

Sep 29, 2025

Revolution Medicines Announces Key Leadership Additions, including Alan Sandler, M.D. as Chief Development Officer - GlobeNewswire Inc.

Sep 29, 2025

Sep 29, 2025

Goldman Sachs Group Inc. Sells 195,795 Shares of ALX Oncology Holdings Inc. $ALXO - Defense World

Sep 29, 2025

Sep 28, 2025

Pan India Corporation Limited Earnings Review What Investors Need to KnowGrowth vs. Value Investing & Interactive Charts for Smarter Trading - earlytimes.in

Sep 28, 2025

Sep 27, 2025

Is Far East Consortium International Limited FET a good long term investmentTechnology Stock Trends & Enter Your Email to Get Stock Alerts - earlytimes.in

Sep 27, 2025

Sep 27, 2025

ALX Oncology Holdings Inc. stock retracement – recovery analysisEarnings Growth Report & High Return Stock Watch Alerts - newser.com

Sep 27, 2025

Sep 27, 2025

What to do if you’re stuck in ALX Oncology Holdings Inc.July 2025 Rallies & High Yield Stock Recommendations - newser.com

Sep 27, 2025

Sep 25, 2025

3 Promising Penny Stocks With Market Caps Under $700M - Yahoo Finance

Sep 25, 2025

Sep 24, 2025

What earnings revisions data tells us about ALX Oncology Holdings Inc.2025 Investor Takeaways & Daily Price Action Insights - newser.com

Sep 24, 2025

Sep 24, 2025

ALX Oncology Holdings Inc. (NASDAQ:ALXO) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Sep 24, 2025

Sep 23, 2025

ALX Oncology (NASDAQ:ALXO) CEO Jason Lettmann Buys 21,070 Shares - MarketBeat

Sep 23, 2025

Sep 22, 2025

Is now a turning point for ALX Oncology Holdings Inc.July 2025 Opening Moves & Verified Chart Pattern Signals - newser.com

Sep 22, 2025

Sep 22, 2025

ALX Oncology (NASDAQ:ALXO) CEO Jason Lettmann Buys 71,163 Shares - MarketBeat

Sep 22, 2025

Sep 21, 2025

CEO & Director of ALX Oncology Holdings Picks Up 69% More Stock - Yahoo Finance

Sep 21, 2025

Sep 21, 2025

Trend Recap: Is SYTA backed by strong institutional buyingJuly 2025 Rallies & Free Accurate Trade Setup Notifications - خودرو بانک

Sep 21, 2025